- 18th Symposium on Infections in the Immunocompromised Host, De 15 a 17 de junho de 2014 - Berlim - Alemanha -Infectious Diseases (Pediatric and Adult) for Primary Care, De 19 a 21 de junho de 2014 - Tennessee - EUA - Curso Internacional Diagnóstico De Levaduras En Micología Médica, De 30 de junho a 04 de julho de 2014 - Chile
FEBRE AMARELA (1)
CÂMARA, F. P.; CARVALHO, L. M. de; GOMES, A. L. Demographic profile of sylvatic yellow fever in Brazil from 1973 to 2008. Transactions of the Royal Society of Tropical Medicine and Hygiene, London, v. 107, n. 5, p. 324-327, May 2013.
(2) (3) (4) (5) (6) (7) (8) (9) (10)
ERICKSON, A. K.; PFEIFFER, J. K. Dynamic viral dissemination in mice infected with yellow fever virus strain 17D. Journal of virology, Washington, v. 87, n. 22, p. 12392-12927, Nov. 2013.
KWALLAH, A. O. et al. A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus. Journal of virological methods, Amsterdam, v. 193, n. 1, p. 23-27, Oct. 2013.
LIRA-VIEIRA, A. R. et al. Ecological aspects of mosquitoes (Diptera: Culicidae) in the gallery forest of Brasília National Park, Brazil, with an emphasis on potential vectors of yellow fever. Revista da Sociedade Brasileira de Medicina Tropical, Brasília, v. 46, n. 5, p. 566-574, Sept./Oct. 2013.
PAULSON, T. Drug development: searching for patterns. Nature, London, v. 507, n. 7490, p. 10-11, Mar. 2014. Suplemento.
QUARESMA, J. S. A. et al. Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever. Reviews in medical virology, Chichester, v. 23, n. 5, p. 305-318, Sept. 2013.
SLIFKA, M. K. et al. Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis. Journal of allergy and clinical immunology, St. Louis, v. 133, n. 2, p. 439-447, Feb. 2014.
TRANQUILIN, M. V. et al. First report of yellow fever virus in non-human primates in the State of Paraná, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, Brasília, v. 46, n. 4, p. 522-524, July/Aug. 2013.
VRATSKIKH, O. et al. Dissection of antibody specificities induced by yellow fever vaccination. PLoS pathogens, San Francisco, v. 9, n. 6, p. e1003458, 2013.
YANG, G. et al. Birth of three stowaway-like MITE families via microhomology-mediated miniaturization of a Tc1/Mariner element in the yellow fever mosquito. Genome biology and evolution, London, v. 5, n. 10, p. 1937-1948, 2013.
INFLUENZA (1) (2) (3) (4) (5)
TEIJARO, J. R.; WALSH, K. B.; RICE, S. ; ROSEN, H. ; OLDSTONE, M. B.
Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proceedings of the national academy of sciences of the United States of America, Washington, v. 111, n. 10, p. 3799-3804, Mar. 2014.
LINSTER, M. et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell, Cambridge, v. 15, n.2, p. 329-339, Apr.2014.
VICTOR, J. F. et al. Fatores associados a vacinacao contra Influenza A (H1N1) em idosos. Revista da Escola de Enfermagem da USP, São Paulo, v. 48, n. 1, p. 57-64, fev. 2014.
KOELLE, K; RASMUSSEN, D. A. Influenza: prediction is worth a shot. Nature, London, v. 507, n. 7490, p. 47-48, Mar. 2014.
VAN DER VELDEN, M. V. et al. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. Journal of infectious diseases, Chicago, v. 209, n. 1, 12-23, Jan. 2014
(1) (2) (3) (4) (5)
LEDFORD, H. Software patents await legal fate. Nature, London, v. 507, n. 7493, p. 410-411, Mar. 2014.
GABBLE, R. ; KOHLER, J. C. To patent or not to patent? The case of Novartis’ cancer drug Glivec in India. Globalization and Health, Bethesda, v. 10, n. 1, p. 3, 2014.
PASCHE, E. et al. Development and tuning of an original search engine for patent libraries in medicinal chemistry. BMC Bioinformatics, London, v. 15, Suppl. 1, p. S15, 2014.
BOHLE, S. Open access: online repository for lab notebooks. Nature, London, v. 506, n. 7487, p. 159, Feb. 2014.
DI NUNZIO, M. C. Managing your patent assets. Neurobiolology of Disease, Orlando, v. 6, p. 25-31, Jan. 2014.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
